Jeffrey Jay Rutgard is a Mililani, Hawaii based male Ophthalmologist who is specialized in Ophthalmology. Active license number of Jeffrey Jay Rutgard is MD16420 for Ophthalmology in Hawaii. Jeffrey Jay Rutgard is medically trained to diagnose, monitor and medically or surgically treat all ocular and visual disorders. This includes problems affecting the eye and its component structures, the eyelids, the orbit and the visual pathways. In so doing, patients can be prescribed vision services, including glasses and contact lenses.
Complete Profile:
Jeffrey Jay Rutgard speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Ophthalmology
Credentials:
M.D.
Gender:
Male
Practice Address:
95-717 Kipapa Drive #23, Mililani, Hawaii, 96789
Phone:
808-888-6217
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1366795155
NPI Enumeration Date:
18 Oct, 2012
NPI Last Update On:
18 Oct, 2012
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Jeffrey Jay Rutgard are as mentioned below.
License Number
Specialization
State
Status
MD16420
Ophthalmology
Hawaii
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
95-717 Kipapa Drive #23, Mililani, Hawaii
Zip:
96789
Phone Number:
808-888-6217
Fax Number:
--
Patients can reach Jeffrey Jay Rutgard at 95-717 Kipapa Drive #23, Mililani, Hawaii or can call to book an appointment on 808-888-6217. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.